{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T04:21:40Z","timestamp":1752985300321,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immunoglobulin light chain (AL) amyloidosis commonly affects the kidney or heart, but may also involve the liver at a histopathological level. Early diagnosis of AL amyloidosis is important for proper management with desirable outcome. We reported here an unusual case of AL amyloidosis, presenting primarily with multiple serous cavity effusion, accompanied with rapidly progressive cholestasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A previously healthy 63-year-old man presented with dysuria, frequent urination, oliguria and oedema of lower extremities for one month, accompanied with jaundice and hypoproteinemia. CT demonstrated multiple serous cavity effusion, focal hypodense lesions in the liver, and focal low-density in the spleen. Laparoscopy with liver biopsy revealed liver and spleen fibrosis with congestion, no visceral rupture, following haemorrhagic ascites from abdominocentesis. This patient was transferred to our (tertiary) hospital. The diagnosis of amyloidosis was confirmed with histopathology\/immunohistochemistry. Haematopoietic stem cell transplantation was not applicable, however chemotherapy was advised, due to the patient\u2019s Mayo score 3. The patient declined chemotherapy and was self-discharged back to his hometown hospital with palliative care, however only lasted a further one-month.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The lesson we have learnt from this case that any patients with multiple serous cavity effusion and isolated hepatic involvement, primary amyloidosis should be considered. Multiple serous cavity effusion may serve as an indicator for poor prognosis of hepatic AL amyloidosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02201-4","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:04:53Z","timestamp":1647605093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["AL amyloidosis with primary presentation of multiple serous cavity effusion and severe cholestasis: a case report and review of literature"],"prefix":"10.1186","volume":"22","author":[{"given":"Kehui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yezhou","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiliang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shisan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-7917","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"issue":"1","key":"2201_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1586\/17474086.2014.858594","volume":"7","author":"G Merlini","year":"2014","unstructured":"Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA. Immunoglobulin light chain amyloidosis. Expert Rev Hematol. 2014;7(1):143\u201356.","journal-title":"Expert Rev Hematol"},{"key":"2201_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1750-1172-7-54","volume":"7","author":"E Desport","year":"2012","unstructured":"Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, Quellard N, Lacombe C, Goujon JM, Lavergne D, et al. Al amyloidosis. Orphanet J Rare Dis. 2012;7:54.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"2201_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/0046-8177(91)90180-W","volume":"22","author":"FS Buck","year":"1991","unstructured":"Buck FS, Koss MN. Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol. 1991;22(9):904\u20137.","journal-title":"Hum Pathol"},{"issue":"8","key":"2201_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.mayocp.2015.06.009","volume":"90","author":"A Dispenzieri","year":"2015","unstructured":"Dispenzieri A, Buadi F, Kumar SK, Reeder CB, Sher T, Lacy MQ, Kyle RA, Mikhael JR, Roy V, Leung N, et al. Treatment of immunoglobulin light chain amyloidosis: mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus statement. Mayo Clin Proc. 2015;90(8):1054\u201381.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2201_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13506129.2017.1414042","volume":"25","author":"GGL Cancado","year":"2018","unstructured":"Cancado GGL, Faria LC, Osorio FMF, Vidigal PVT, Couto CA, Ferrari TCA. Budd Chiari syndrome associated with AL amyloidosis: a coagulation paradox. Amyloid. 2018;25(1):70\u20131.","journal-title":"Amyloid"},{"issue":"2","key":"2201_CR6","first-page":"130","volume":"37","author":"TO Tiryaki","year":"2020","unstructured":"Tiryaki TO, Yonal Hindilerden I, Yegen G, Nalcaci M. Budd-Chiari syndrome: an unusual complication of AL amyloidosis. Turk J Haematol. 2020;37(2):130\u20131.","journal-title":"Turk J Haematol"},{"issue":"14","key":"2201_CR7","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","volume":"29","author":"G Merlini","year":"2011","unstructured":"Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol. 2011;29(14):1924\u201333.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2201_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/01.md.0000091183.93122.c7","volume":"82","author":"MA Park","year":"2003","unstructured":"Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore). 2003;82(5):291\u20138.","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 1","key":"2201_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/13506129.2011.574354040","volume":"18","author":"L Econimo","year":"2011","unstructured":"Econimo L, Jeannin G, Biasi L, Mazzola G, Mendeni M, Presteni K, Gregorini G. Liver involvement with rapidly progressive course in light chain (AL) amyloidosis: distinguishing features at presentation Experience of a single center. Amyloid. 2011;18(Suppl 1):109\u201311.","journal-title":"Amyloid"},{"issue":"3","key":"2201_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12016-019-08759-4","volume":"59","author":"V D'Aguanno","year":"2020","unstructured":"D\u2019Aguanno V, Ralli M, Artico M, Russo FY, Scarpa A, Fiore M, Tirassa P, Severini C, de Vincentiis M, Greco A. Systemic amyloidosis: a contemporary overview. Clin Rev Allergy Immunol. 2020;59(3):304\u201322.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"2201_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4254\/wjh.v8.i6.340","volume":"8","author":"N Sonthalia","year":"2016","unstructured":"Sonthalia N, Jain S, Pawar S, Zanwar V, Surude R, Rathi PM. Primary hepatic amyloidosis: a case report and review of literature. World J Hepatol. 2016;8(6):340\u20134.","journal-title":"World J Hepatol"},{"issue":"2","key":"2201_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, Jia J, Tian Q, Aggarwal R, Muljono DH, et al. Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2020;5(2):167\u2013228.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"2201_CR13","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3748\/wjg.v24.i10.1134","volume":"24","author":"W Zhang","year":"2018","unstructured":"Zhang W, Wang QZ, Chen XW, Zhong HS, Zhang XT, Chen XD, Xu K. Budd-Chiari syndrome in China: a 30-year retrospective study on survival from a single center. World J Gastroenterol. 2018;24(10):1134\u201343.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02201-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:08:02Z","timestamp":1647605282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02201-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02201-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the son of the patient. Copy of the consent form is available for review by the Editor of BMC Gastroenterology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}